Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana

References

• Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981; 290:713 - 7; http://dx.doi.org/10.1038/290713a0; PMID: 6163993
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057 - 62; PMID: 20798667
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:470 - 2; PMID: 19444151
   PubMedGoogle Scholar
• Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880 - 7; http://dx.doi.org/10.1001/jama.2009.1536; PMID: 19822626
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 – April 10, 2010. May 14, 2010. http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm (accessed 30 May 2014).
   Google Scholar
• Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990; 8:737 - 71; http://dx.doi.org/10.1146/annurev.iy.08.040190.003513; PMID: 2188678
   PubMed Web of Science ®Google Scholar
• Han T, Marasco WA. Structural basis of influenza virus neutralization. Ann N Y Acad Sci 2011; 1217:178 - 90; http://dx.doi.org/10.1111/j.1749-6632.2010.05829.x; PMID: 21251008
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. News Release 01/16/2013. FDA approves new seasonal influenza vaccine made using novel technology. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm335891.htm (accessed 02 June 2014).
   Google Scholar
• Chichester JA, Yusibov V. Plants as alternative systems for production of vaccines. Hum Vaccin 2007; 3:146 - 8; http://dx.doi.org/10.4161/hv.3.4.4148; PMID: 17643065
   PubMed Web of Science ®Google Scholar
• Mett V, Farrance CE, Green BJ, Yusibov V. Plants as biofactories. Biologicals 2008; 36:354 - 8; http://dx.doi.org/10.1016/j.biologicals.2008.09.001; PMID: 18938088
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010; 8:620 - 37; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x; PMID: 20233333
   PubMed Web of Science ®Google Scholar
• Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul AM, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 2007; 1:19 - 25; http://dx.doi.org/10.1111/j.1750-2659.2006.00005.x; PMID: 19453476
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, Musiychuk K, Bi H, Farrance C, Shamloul M, et al. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin 2011; 7:Suppl 41 - 50; http://dx.doi.org/10.4161/hv.7.0.14561; PMID: 21266846
   PubMed Web of Science ®Google Scholar
• Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V, Fraunhofer USA Center for Molecular Biotechnology Study Group. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine 2014; 32:2251 - 9; http://dx.doi.org/10.1016/j.vaccine.2013.10.017; PMID: 24126211
   PubMed Web of Science ®Google Scholar
• Vanlandschoot P, Beirnaert E, Neirynck S, Saelens X, Jou WM, Fiers W. Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells. Arch Virol 1996; 141:1715 - 26; http://dx.doi.org/10.1007/BF01718294; PMID: 8893793
   PubMed Web of Science ®Google Scholar
• Shoji Y, Jones RM, Mett V, Chichester JA, Musiychuk K, Sun X, Tumpey TM, Green BJ, Shamloul M, Norikane J, et al. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge. Hum Vaccin Immunother 2013; 9:553 - 60; http://dx.doi.org/10.4161/hv.23234; PMID: 23296194
   PubMed Web of Science ®Google Scholar
• Grgacic EV, Anderson DA. Virus-like particles: passport to immune recognition. Methods 2006; 40:60 - 5; http://dx.doi.org/10.1016/j.ymeth.2006.07.018; PMID: 16997714
   PubMed Web of Science ®Google Scholar
• Chackerian B. Virus-like particles: flexible platforms for vaccine development. Expert Rev Vaccines 2007; 6:381 - 90; http://dx.doi.org/10.1586/14760584.6.3.381; PMID: 17542753
   PubMed Web of Science ®Google Scholar
• Kushnir N, Streatfield SJ, Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 2012; 31:58 - 83; http://dx.doi.org/10.1016/j.vaccine.2012.10.083; PMID: 23142589
   PubMed Web of Science ®Google Scholar
• Recombivax HB®. Prescribing information. Merck; July 2011
   Google Scholar
• Gardasil®. Prescribing information. Merck; April 2011
   Google Scholar
• Cervarix®. Prescribing information. GlaxoSmithKline; July 2011
   Google Scholar
• Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 2001; 75:6154 - 65; http://dx.doi.org/10.1128/JVI.75.13.6154-6165.2001; PMID: 11390617
   PubMed Web of Science ®Google Scholar
• Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005; 23:5751 - 9; http://dx.doi.org/10.1016/j.vaccine.2005.07.098; PMID: 16143432
   PubMed Web of Science ®Google Scholar
• Chen BJ, Leser GP, Morita E, Lamb RA. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 2007; 81:7111 - 23; http://dx.doi.org/10.1128/JVI.00361-07; PMID: 17475660
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Lavoie PO, Couture MM, Trépanier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, Vézina LP. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J 2008; 6:930 - 40; http://dx.doi.org/10.1111/j.1467-7652.2008.00384.x; PMID: 19076615
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, Ors F, Vézina LP. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010; 8:607 - 19; http://dx.doi.org/10.1111/j.1467-7652.2009.00496.x; PMID: 20199612
   PubMed Web of Science ®Google Scholar
• Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010; 5:e15559; http://dx.doi.org/10.1371/journal.pone.0015559; PMID: 21203523
   PubMed Web of Science ®Google Scholar
• The Business Journals. Medicago Inc. Press Release June 8, 2011. Medicago reports positive U.S. clinical trial results for its H1N1/seasonal influenza vaccine. http://www.bizjournals.com/prnewswire/press_releases/2011/06/08/TO211 (accessed 30 May 2014).
   Google Scholar
• The Business Journals. Medicago Inc. Press Release June 30, 2011. Medicago reports positive Phase II final results for its avian flu pandemic vaccine. http://www.bizjournals.com/prnewswire/press_releases/2011/06/30/TO669 (accessed 30 May 2014).
   Google Scholar
• Link A, Zabel F, Schnetzler Y, Titz A, Brombacher F, Bachmann MF. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J Immunol 2012; 188:3724 - 33; http://dx.doi.org/10.4049/jimmunol.1103312; PMID: 22427639
   PubMed Web of Science ®Google Scholar
• Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009; 27:1087 - 92; http://dx.doi.org/10.1016/j.vaccine.2008.11.108; PMID: 19100806
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008; 26:2930 - 4; http://dx.doi.org/10.1016/j.vaccine.2008.03.045; PMID: 18440103
   PubMed Web of Science ®Google Scholar